EN IT

Reserved

Autodesk: May's recovery is over, the decline picks up pace

·43 min read
EXECUTIVE VIEW

At week 9 of the sell signal on Autodesk, the week closed with a 13.7% drop and heavy distribution. May's recovery attempt was wiped out in a single session: CMF sharply lower, momentum accelerating to the downside, MACD histogram back in negative territory. The double bottom in the 218 ar

Reserved analysis Subscribe to read →
Reserved

Archer-Daniels-Midland: +23% in 21 weeks, distribution lurking

·44 min read
EXECUTIVE VIEW

At week 21 of the buy signal, Archer-Daniels-Midland has completed the model's coverage and the remaining 40% is still live at +23%. The structural trailing stop protects the gain; the technical picture shows mixed signals worth watching closely.

Reserved analysis Subscribe to read →
Reserved

Adobe: sharp drop, but the double bottom calls for caution

·43 min read
EXECUTIVE VIEW

Adobe receives a fresh sell signal after a week of sharp decline. A signal strength of 95 out of 100 is not a confirmation of the downtrend: it is amplitude to read as possible exhaustion. On the daily chart a double bottom in the 232 area and buyers at 81% signal counter-pressure. Trading

Reserved analysis Subscribe to read →
Reserved

Accenture: Decline Resumes After the Rebound, CMF Weakening

·43 min read
EXECUTIVE VIEW

Accenture is at week 18 of a sell signal, up 29% from inception. The week closes lower after a two-week rebound: CMF loses momentum and the MOM accelerates to the downside. The double bottom in the 160 area is the variable to watch.

Reserved analysis Subscribe to read →
Reserved

Archer Aviation: sell signal in week one, but the model advises against opening

·43 min read
EXECUTIVE VIEW

Archer Aviation Inc enters week one of a sell signal, ranking 25th among 114 US sell signals. Elevated volatility and absent directionality make an opening high-risk per our model.

Reserved analysis Subscribe to read →
Reserved

Abbott Laboratories: sell signal at week 12, trade up +16%

·43 min read
EXECUTIVE VIEW

Abbott Laboratories is at week 12 of a sell signal, with the trade up 16%. The latest week closed down 3.2% with sellers at 78% of volume. Indicators show a decline that holds, but with technical signals evolving.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn